{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T13:42:24Z","timestamp":1790516544554,"version":"4.1.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,17]],"date-time":"2020-09-17T00:00:00Z","timestamp":1600300800000},"content-version":"vor","delay-in-days":2543,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Lipid Research"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1194\/jlr.m037622","type":"journal-article","created":{"date-parts":[[2013,7,19]],"date-time":"2013-07-19T01:50:54Z","timestamp":1374198654000},"page":"2884-2897","source":"Crossref","is-referenced-by-count":81,"title":["Alterations in cerebrospinal fluid glycerophospholipids and phospholipase A2 activity in Alzheimer's disease"],"prefix":"10.1016","volume":"54","author":[{"given":"Alfred N.","family":"Fonteh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiarong","family":"Chiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Cipolla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack","family":"Hale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatimatou","family":"Diallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandra","family":"Chirino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianghong","family":"Arakaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael G.","family":"Harrington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1194\/jlr.M037622_bib1","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1194\/jlr.R800095-JLR200","article-title":"Update of the LIPID MAPS comprehensive classification system for lipids","volume":"50","author":"Fahy","year":"2009","journal-title":"J. Lipid Res."},{"key":"10.1194\/jlr.M037622_bib2","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/978-1-4020-8831-5_9","article-title":"Altered lipid metabolism in brain injury and disorders","volume":"49","author":"Adibhatla","year":"2008","journal-title":"Subcell. Biochem."},{"key":"10.1194\/jlr.M037622_bib3","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1385\/MN:32:1:089","article-title":"Lipid signaling in neural plasticity, brain repair, and neuroprotection","volume":"32","author":"Bazan","year":"2005","journal-title":"Mol. Neurobiol."},{"key":"10.1194\/jlr.M037622_bib4","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1155\/2006\/202938","article-title":"Identification of disease markers in human cerebrospinal fluid using lipidomic and proteomic methods","volume":"22","author":"Fonteh","year":"2006","journal-title":"Dis. Markers."},{"key":"10.1194\/jlr.M037622_bib5","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/nrn2233","article-title":"A neuroscientist's guide to lipidomics","volume":"8","author":"Piomelli","year":"2007","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1194\/jlr.M037622_bib6","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1385\/JMN:16:2-3:243","article-title":"In vivo fatty acid incorporation into brain phosholipids in relation to plasma availability, signal transduction and membrane remodeling","volume":"16","author":"Rapoport","year":"2001","journal-title":"J. Mol. Neurosci."},{"key":"10.1194\/jlr.M037622_bib7","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0005-2760(88)90200-7","article-title":"Hydrolysis of 1-alkyl-2-arachidonoyl-sn-glycero-3-phosphocholine, a common precursor of platelet-activating factor and eicosanoids, by human platelet phospholipase A2","volume":"959","author":"Kramer","year":"1988","journal-title":"Biochim. Biophys. Acta."},{"key":"10.1194\/jlr.M037622_bib8","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.plefa.2004.03.004","article-title":"Brain phospholipases A2: a perspective on the history","volume":"71","author":"Farooqui","year":"2004","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids."},{"key":"10.1194\/jlr.M037622_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1388-1981(00)00105-0","article-title":"The expanding superfamily of phospholipase A(2) enzymes: classification and characterization","volume":"1488","author":"Six","year":"2000","journal-title":"Biochim. Biophys. Acta."},{"key":"10.1194\/jlr.M037622_bib10","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0891-5849(98)00211-1","article-title":"Susceptibility of plasmenyl glycerophosphoethanolamine lipids containing arachidonate to oxidative degradation","volume":"26","author":"Khaselev","year":"1999","journal-title":"Free Radic. Biol. Med."},{"key":"10.1194\/jlr.M037622_bib11","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S1388-1981(00)00153-0","article-title":"Lecithin cholesterol acyltransferase","volume":"1529","author":"Jonas","year":"2000","journal-title":"Molecular and Cell Biology of Lipids."},{"key":"10.1194\/jlr.M037622_bib12","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1016\/j.jchromb.2009.01.008","article-title":"Lipidomic analysis of endocannabinoid metabolism in biological samples","volume":"877","author":"Astarita","year":"2009","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"key":"10.1194\/jlr.M037622_bib13","doi-asserted-by":"crossref","first-page":"237","DOI":"10.2174\/092986607780090829","article-title":"Critical enzymes involved in endocannabinoid metabolism","volume":"14","author":"Basavarajappa","year":"2007","journal-title":"Protein Pept. Lett."},{"key":"10.1194\/jlr.M037622_bib14","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/S0165-6147(00)01482-6","article-title":"The endocannabinoid system as a target for therapeutic drugs","volume":"21","author":"Piomelli","year":"2000","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1194\/jlr.M037622_bib15","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.prostaglandins.2008.12.002","article-title":"Biology of endocannabinoid synthesis system","volume":"89","author":"Wang","year":"2009","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"10.1194\/jlr.M037622_bib16","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0300-483X(00)00199-2","article-title":"Phospholipid signaling in apoptosis: peroxidation and externalization of phosphatidylserine","volume":"148","author":"Tyurina","year":"2000","journal-title":"Toxicology."},{"key":"10.1194\/jlr.M037622_bib17","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/BF01001351","article-title":"Neurochemical aspects of Alzheimer's disease: involvement of membrane phospholipids","volume":"3","author":"Farooqui","year":"1988","journal-title":"Metab. Brain Dis."},{"key":"10.1194\/jlr.M037622_bib18","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.3390\/ijms14011310","article-title":"Phospholipids and Alzheimer's disease: alterations, mechanisms and potential biomarkers","volume":"14","author":"Kosicek","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"10.1194\/jlr.M037622_bib19","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/BF02536067","article-title":"Fatty acid composition of brain phospholipids in aging and in Alzheimer's disease","volume":"26","author":"S\u00f7derberg","year":"1991","journal-title":"Lipids."},{"key":"10.1194\/jlr.M037622_bib20","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1042\/bst0260243","article-title":"Plasmalogen-selective phospholipase A2 and its involvement in Alzheimer's disease","volume":"26","author":"Farooqui","year":"1998","journal-title":"Biochem. Soc. Trans."},{"key":"10.1194\/jlr.M037622_bib21","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s00702-004-0142-y","article-title":"Platelet phospholipase A2 activity in Alzheimer's disease and mild cognitive impairment","volume":"111","author":"Gattaz","year":"2004","journal-title":"J. Neural Transm."},{"key":"10.1194\/jlr.M037622_bib22","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1046\/j.1471-4159.1998.70020786.x","article-title":"Phospholipid-metabolizing enzymes in Alzheimer's disease: increased lysophospholipid acyltransferase activity and decreased phospholipase A2 activity","volume":"70","author":"Ross","year":"1998","journal-title":"J. Neurochem."},{"key":"10.1194\/jlr.M037622_bib23","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1006\/nbdi.1996.0005","article-title":"Cytosolic phospholipase A2 (cPLA2) immunoreactivity is elevated in Alzheimer's disease brain","volume":"3","author":"Stephenson","year":"1996","journal-title":"Neurobiol. Dis."},{"key":"10.1194\/jlr.M037622_bib24","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1743-8454-6-10","article-title":"The morphology and biochemistry of nanostructures provide evidence for synthesis and signaling functions in human cerebrospinal fluid","volume":"6","author":"Harrington","year":"2009","journal-title":"Cerebrospinal Fluid Res."},{"key":"10.1194\/jlr.M037622_bib25","first-page":"263","article-title":"The diagnosis of dementia due to Alzheimer's disease: recommendation from the National Institute on Aging Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimer's Dement","volume":"77","author":"McKhann","year":"2011"},{"issue":"Suppl. 1","key":"10.1194\/jlr.M037622_bib26","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1017\/S1041610297004870","article-title":"Clinical dementia rating: a reliable and valid diagnostic and staging measure for dementia of the Alzheimer type","volume":"9","author":"Morris","year":"1997","journal-title":"Int. Psychogeriatr."},{"key":"10.1194\/jlr.M037622_bib27","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1365-2796.2004.01388.x","article-title":"Mild cognitive impairment as a diagnostic entity","volume":"256","author":"Petersen","year":"2004","journal-title":"J. Intern. Med."},{"key":"10.1194\/jlr.M037622_bib28","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1139\/y59-099","article-title":"A rapid method of total lipid extraction and purification","volume":"37","author":"Bligh","year":"1959","journal-title":"Can. J. Biochem. Physiol."},{"key":"10.1194\/jlr.M037622_bib29","series-title":"Mass Spectrometry of Phospholipids: Tables of Molecular and Product Ions","author":"Murphy","year":"2002"},{"key":"10.1194\/jlr.M037622_bib30","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/(SICI)1096-9888(200002)35:2<224::AID-JMS933>3.0.CO;2-G","article-title":"Analysis of oxidized glycerophosphocholine lipids using electrospray ionization mass spectrometry and microderivatization techniques","volume":"35","author":"Harrison","year":"2000","journal-title":"J. Mass Spectrom."},{"key":"10.1194\/jlr.M037622_bib31","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S1050-1738(01)00100-1","article-title":"Oxidized LDL contains inflammatory PAF-like phospholipids","volume":"11","author":"Marathe","year":"2001","journal-title":"Trends Cardiovasc. Med."},{"key":"10.1194\/jlr.M037622_bib32","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1006\/abio.1994.1461","article-title":"A continuous fluorescence-based assay for the human high-molecular- weight cytosolic phospholipase A2","volume":"222","author":"Huang","year":"1994","journal-title":"Anal. Biochem."},{"key":"10.1194\/jlr.M037622_bib33","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1155\/2006\/158797","article-title":"Protein analysis in human cerebrospinal fluid: physiological aspects, current progress and future challenges","volume":"22","author":"Huhmer","year":"2006","journal-title":"Dis. Markers."},{"key":"10.1194\/jlr.M037622_bib34","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1002\/mas.20023","article-title":"Shotgun lipidomics: electrospray ionization mass spectrometric analysis and quantitation of cellular lipidomes directly from crude extracts of biological samples","volume":"24","author":"Han","year":"2005","journal-title":"Mass Spectrom. Rev."},{"key":"10.1194\/jlr.M037622_bib35","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ymeth.2006.05.014","article-title":"Lipidomics: an analysis of cellular lipids by ESI-MS","volume":"39","author":"Milne","year":"2006","journal-title":"Methods."},{"key":"10.1194\/jlr.M037622_bib36","doi-asserted-by":"crossref","first-page":"5470","DOI":"10.1016\/j.chroma.2011.06.025","article-title":"Measurement of phospholipids by hydrophilic interaction liquid chromatography coupled to tandem mass spectrometry: the determination of choline containing compounds in foods","volume":"1218","author":"Zhao","year":"2011","journal-title":"J. Chromatogr. A."},{"key":"10.1194\/jlr.M037622_bib37","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.1016\/j.bbamem.2012.02.002","article-title":"Chemistry of phospholipid oxidation","volume":"1818","author":"Reis","year":"2012","journal-title":"Biochim. Biophys. Acta."},{"key":"10.1194\/jlr.M037622_bib38","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.bbalip.2012.08.019","article-title":"N-acylation of phosphatidylethanolamine and its biological functions in mammals","volume":"1831","author":"Wellner","year":"2013","journal-title":"Biochim. Biophys. Acta."},{"key":"10.1194\/jlr.M037622_bib39","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/j.bbalip.2010.08.010","article-title":"Enzymological studies on the biosynthesis of N-acylethanolamines","volume":"1801","author":"Ueda","year":"2010","journal-title":"Biochim. Biophys. Acta."},{"key":"10.1194\/jlr.M037622_bib40","doi-asserted-by":"crossref","first-page":"26465","DOI":"10.1074\/jbc.M604660200","article-title":"Endocannabinoid biosynthesis proceeding through glycerophospho-N-acyl ethanolamine and a role for alpha\/beta-hydrolase 4 in this pathway","volume":"281","author":"Simon","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1194\/jlr.M037622_bib41","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/alzrt154","article-title":"Plasma lipoprotein-associated phospholipase A2 activity in Alzheimer's disease, amnestic mild cognitive impairment, and cognitively healthy elderly subjects: a cross-sectional study","volume":"4","author":"Davidson","year":"2012","journal-title":"Alzheimers Res. Ther."},{"key":"10.1194\/jlr.M037622_bib42","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.neulet.2010.06.046","article-title":"Phospholipids and a phospholipid-rich diet alter the in vitro amyloid-beta peptide levels and amyloid-beta 42\/40 ratios","volume":"481","author":"Amtul","year":"2010","journal-title":"Neurosci. Lett."},{"key":"10.1194\/jlr.M037622_bib43","doi-asserted-by":"crossref","first-page":"5879","DOI":"10.3390\/ijms14035879","article-title":"Effect of different phospholipids on alpha-secretase activity in the non-amyloidogenic pathway of Alzheimer's disease","volume":"14","author":"Grimm","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"10.1194\/jlr.M037622_bib44","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1523\/JNEUROSCI.5177-11.2012","article-title":"Cdk5\/p25-induced cytosolic PLA2-mediated lysophosphatidylcholine production regulates neuroinflammation and triggers neurodegeneration","volume":"32","author":"Sundaram","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1194\/jlr.M037622_bib45","article-title":"Critical role of cPLA2 in Abeta oligomer-induced neurodegeneration and memory deficit","volume":"33","author":"Desb\u0450ne","year":"2012","journal-title":"Neurobiol. Aging."},{"key":"10.1194\/jlr.M037622_bib46","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1146\/annurev.nutr.012809.104635","article-title":"Docosahexaenoic acid signalolipidomics in nutrition: significance in aging, neuroinflammation, macular degeneration, Alzheimer's, and other neurodegenerative diseases","volume":"31","author":"Bazan","year":"2011","journal-title":"Annu. Rev. Nutr."},{"key":"10.1194\/jlr.M037622_bib47","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S1098-3597(01)90046-8","article-title":"Treatment of Alzheimer's disease","volume":"3","author":"Cummings","year":"2001","journal-title":"Clin. Cornerstone."},{"key":"10.1194\/jlr.M037622_bib48","first-page":"85","article-title":"Alzheimer's disease, amnestic mild cognitive impairment, and age-associated memory impairment: current understanding and progress toward integrative prevention","volume":"13","author":"Kidd","year":"2008","journal-title":"Altern. Med. Rev."},{"key":"10.1194\/jlr.M037622_bib49","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1002\/pro.678","article-title":"Lipid composition influences the release of Alzheimer's amyloid beta-peptide from membranes","volume":"20","author":"Lemkul","year":"2011","journal-title":"Protein Sci."},{"key":"10.1194\/jlr.M037622_bib50","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1194\/jlr.M002287","article-title":"Secretory phospholipase A2 type III enhances alpha-secretase-dependent amyloid precursor protein processing through alterations in membrane fluidity","volume":"51","author":"Yang","year":"2010","journal-title":"J. Lipid Res."},{"key":"10.1194\/jlr.M037622_bib51","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.biochi.2011.04.023","article-title":"Occurrence, biosynthesis and functions of N-acylphosphatidylethanolamines (NAPE): not just precursors of N-acylethanolamines (NAE)","volume":"94","author":"Coulon","year":"2012","journal-title":"Biochimie."},{"key":"10.1194\/jlr.M037622_bib52","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0361-9230(99)00027-1","article-title":"Inhibitors of intracellular phospholipase A2 activity: their neurochemical effects and therapeutical importance for neurological disorders","volume":"49","author":"Farooqui","year":"1999","journal-title":"Brain Res. Bull."},{"key":"10.1194\/jlr.M037622_bib53","doi-asserted-by":"crossref","first-page":"85","DOI":"10.2174\/1568006043481239","article-title":"Neuroprotection abilities of cytosolic phospholipase A2 inhibitors in kainic acid-induced neurodegeneration","volume":"4","author":"Farooqui","year":"2004","journal-title":"Curr. Drug Targets Cardiovasc. Haematol. Disord."}],"container-title":["Journal of Lipid Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022227520353141?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022227520353141?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1194\/jlr.M037622","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,20]],"date-time":"2021-11-20T19:00:47Z","timestamp":1637434847000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022227520353141"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":53,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S0022227520353141"],"URL":"https:\/\/doi.org\/10.1194\/jlr.m037622","relation":{},"ISSN":["0022-2275"],"issn-type":[{"value":"0022-2275","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]}}}